Related Experiment Videos
Third-line salvage chemotherapy in Hodgkin's disease
Seminars in Oncology
|March 1, 1985
Abstract:
CEP (CCNU, etoposide, and prednimustine) was tested as third-line chemotherapy in 40 patients resistant to both MOPP and ABVD. The observed response rate (complete remission, 35%, and partial remission, 25%) is encouraging. Treatment was generally well tolerated and all acute side effects were reversible.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Transsphenoidal adenomectomy for GH-, PRL- and ACTH-secreting pituitary tumours: outcome analysis in a series of 125 patients.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2004
[Italian Registry of Dialysis and Transplantation: 1996-2001 experience].
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2004
Metabolism of adenosine in human colorectal tumour.
Nucleosides, nucleotides & nucleic acids·2004
Postoperative spondylodiscitis from Aspergillus fumigatus in immunocompetent subjects.
Journal of neurosurgical sciences·2004
Observation and properties of the X(3872) decaying to J/psipi(+)pi(-) in pp collisions at sqrt[s]=1.96 TeV.
Physical review letters·2004
From imaging to action: MRI features direct surgical strategy in low rectal cancer.
Seminars in oncology·2026
Treatment Initiation of Definitive Radiotherapy in Patients With Locally Advanced Head and Neck Cancer.
Cancer control : journal of the Moffitt Cancer Center·2026
Octreotide as Adjunctive Therapy for Catecholamine-Secreting Pheochromocytoma and Paraganglioma.
The Journal of clinical endocrinology and metabolism·2026
Zanubrutinib versus fludarabine, cyclophosphamide and rituximab in fit, treatment-naïve patients with chronic lymphocytic leukemia: a matching-adjusted indirect comparison.
Journal of comparative effectiveness research·2026